CervoMed share price logo

CervoMed

NASDAQ: CRVO

$2.31

+0.07

(+3.12%)

as on

CervoMed Stock Performance

as on October 20, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $2.18
    $2.35
    downward going graph

    5.63%

    Downside

    1.73%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.13
    $10.00
    downward going graph

    7.79%

    Downside

    332.90%

    Upside

    downward going graph

CervoMed share price movements today

Previous Close
$2.24
Open
$2.27
Volume
558.2K
Market Cap
$33.9M
Day's Low - High
$2.18 - $2.35
52 Week Low - High
$2.13 - $10.00

CervoMed Historical Returns

1 Month Return
-4.94 %
3 Month Return
-17.2 %
1 Year Return
-69.24 %
3 Year Return
-79.38 %
5 Year Return
0 %

CervoMed Stock Fundamentals & Key Indicators

Check CervoMed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$33.9M

EPS (TTM)

-3.21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.7

Industry PE ratio

-3.10

PEG Ratio

0.03

EBITDA

-30.3M

Revenue (TTM)

322.6K

Profit Margin

100.00%

Return On Equity TTM

-156.02%

CervoMed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CervoMed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$33.9MNA-0.70100.00%0.00%
Neutral$87.0B-31.87%-27.32-12.57%0.00%
StrongBuy$126.7B170.61%28.8586.04%0.00%
Buy$81.4B38.98%18.8884.86%0.47%

Stock Returns calculator for CervoMed Stock including INR - Dollar returns

The CervoMed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

CervoMed investment value today

Current value as on today

₹33,228

Returns

-₹66,772

(-66.77%)

Returns from CervoMed Stock

-₹69,241 (-69.24%)

Dollar Impact

₹2,469 (+2.47%)

Analyst Recommendation on CervoMed Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for CervoMed. Average target price of $15

CervoMed Share Price Target

Get share price movements and forecasts by analysts on CervoMed.

What analysts predicted

84.6%UPSIDE

Target Price

$15

Current Price

$2.31

Analyzed by

2 Analysts

High

$18

Target

$15.00

Low

$12

CervoMed target price $15, a slight upside of 84.6% compared to current price of $2.31. According to 2 analysts rating.

Indian Investors' Interest in CervoMed Stock

Search interest for CervoMed Stock has increased by 169% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:169% versus previous 30 day period

CervoMed Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
0
-
-
-
Gross Profit
-
-
-
-
-
-
0
-
-
-
Operating Income
-2
-2
-2
-5
-5
-6
-8
-8
-8
-6
EBITDA
2
-2
-2
-4
-4
-6
-7
-8
-7
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
2
-2
-2
-4
-4
-6
-7
-8
-7
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
2
-2
-2
-4
-4
-6
-7
-8
-7
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
0.00%

CervoMed Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
-
-
Operating Income
-11
-12
-11
-15
-24
-3
-7
-18
-28
EBITDA
0
-18
-11
-15
-15
-5
-2
-16
-26
Interest Expense
2
-
-
-
-
0
-
-
-
Depreciation
0
0
0
0
0
-
-
-
-
Income Before Tax
-2
-18
-11
-15
-24
-5
-2
-16
-26
Income Tax Expense
-1
0
0
-1
0
-
-
-
-
Net Income
-1
-18
-11
-14
-24
-5
-2
-16
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

CervoMed Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
2
-2
-2
-4
-4
-6
-7
-8
-7
-6
Operating Cash Flow
2
-1
-2
-4
-3
-6
-6
-6
-8
-6
Investing Cash Flow
-12
-
-40
2
5
0
7
5
7
2
Financing Cash Flow
11
-
46
0
-
4
-
-
0
18
Change in Cash
-4
-1
3
-2
1
-2
1
-1
0
14

CervoMed Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Dec 2025
Net Income
-1
-18
-11
-14
-24
-5
-2
-16
-26
Operating Cash Flow
-12
-10
-9
-13
-14
-2
-7
-16
-23
Investing Cash Flow
0
-
-
-
0
-
-
-28
18
Financing Cash Flow
20
9
16
17
33
-
11
46
4
Change in Cash
7
0
6
4
18
-33
3
1
0

Global Institutional Holdings in CervoMed

Check out the Institutions with significant holdings in CervoMed.

Funds
Holdings
Michael Rockefeller
4.56%
VANGUARD INDEX FUNDS
2.09%
Vanguard
2.09%
Fidelity Concord Street Trust
0.36%
iShares
0.20%

CervoMed News & Key Events

  • img

    Today's Timeline - 12 October

    Mon, 05:00 PM

    -

    CervoMed announces initial data showing a reduction in neurofilament light chain levels in Phase 2a trial for nfvPPA.

Insights on CervoMed

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CRVO stock has moved up by 1.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 732.9% return, outperforming this stock by 802.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 182.2% return, outperforming this stock by 261.6%

About CervoMed

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
OrganisationCervoMed
Headquarters20 Park Plaza, Boston, MA, 02116, US
IndustryBiotechnology
CEOJohn J. Alam

Key Management of CervoMed

Name

Title

Dr. Sylvie L. Gregoire Pharm.D.

Co-Founder & Director

Mr. William Robert Elder J.D.

CFO, General Counsel & Corporate Secretary

Ms. Kelly Blackburn M.H.A.

Executive Vice President of Clinical Development

Dr. Marinus Verwijs Ph.D.

Executive Vice President of Technical Operations

Dr. Mark A. De Rosch Ph.D.

Executive VP of Regulatory, Government Affairs & Program Management

Dr. Claudia Ordonez M.D.

Senior Vice President of Medical Science

Dr. Matthew Winton Ph.D.

Chief Commercial & Business Officer

Dr. John J. Alam M.D.

Co-Founder, CEO, President & Director

FAQs

What is CervoMed share price today?

CervoMed share price today is $2.31 as on at the close of the market. CervoMed share today touched a day high of $2.35 and a low of $2.18.

What is the 52 week high and 52 week low for CervoMed share?

CervoMed share touched a 52 week high of $10.00 on and a 52 week low of $2.13 on . CervoMed stock price today i.e. is closed at $2.31,which is 76.90% down from its 52 week high and 8.45% up from its 52 week low.

What is CervoMed's market capitalisation today?

CervoMed market capitalisation is $0.00T as on .

How to invest in CervoMed Stock (CRVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CervoMed on INDmoney app. Click on Buy button.

What is the minimum amount required to buy CervoMed Stock (CRVO) from India?

Indian investors can start investing in CervoMed (CRVO) shares with as little as ₹94.93000030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.30 in CervoMed stock (as per the Rupee-Dollar exchange rate as on ). Based on CervoMed share’s latest price of $2.31 as on October 20, 2026 at 8:45 am IST, you will get 4.3290 shares of CervoMed. Learn more about fractional shares .